ArticleIndian journal of pediatrics2026
Development of a Simple Clinical Risk Score for Mortality Prediction in Neonatal Gram-Negative Sepsis.
Article in Indian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo identify clinical and laboratory predictors of mortality and develop a simple bedside risk score for neonates with Gram-negative sepsis.
methodsA total of 50 neonates satisfying as per the inclusion criteria during the reference period were included in the study. Independent predictors of mortality were identified using univariable and multivariable binary logistic regression and Least Absolute Shrinkage and Selection Operator (LASSO) regression, and were used to develop a Neonatal Risk Scoring System (NRSS).
resultsMortality occurred in 38% (19/50). On multivariable analysis, necrotizing enterocolitis (NEC) ≥ Stage II (OR 45.24, p = 0.003), refractory shock (OR 6.54, p = 0.047), and leukopenia (OR 20.01, p = 0.018) independently predicted mortality. The NRSS (weights 8, 4, and 6, respectively) showed excellent discrimination (AUC > 0.9). Mean NRSS was higher in non-survivors (9.47 ± 5.37) vs. survivors (1.74 ± 2.35, p < 0.001). A cut-off ≥ 7 predicted mortality with 73.7% sensitivity and 96.8% specificity.
conclusionsNEC ≥ Stage II, refractory shock, and leukopenia independently predict mortality. The NRSS provides a simple, reliable tool for early risk stratification.
Indexed as
Identifiers
42176111What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.